fbpx Skip to main content

Subscribe to Biocom California’s Life Science Public Policy Newsletter

Senate Appropriations Committee Holds Hearing on FDA Budget Request

  • 2021-06-17T15:00:00.000+0000
  • Author: Izzie Omer

On June 10, the Senate Appropriations Committee held a hearing on the Food and Drug Administration’s (FDA) FY 2022 budget request. Janet Woodcock, Acting Commissioner for the FDA, testified and defended the agency’s new priorities and the request for an increase of $322 million in total budget authority. This increase would support a wide array of activities at FDA, including drug inspections, tobacco use among teens, livestock feed ingredients, and the ongoing opioid crisis.

One of the largest increases ($97 million) would focus on FDA’s core safety programs, particularly device shortages. FDA aims to play a better role in controlling and monitoring shortages that were highlighted by the covid-19 pandemic. FDA also requested $76 million to support data modernization efforts. The investment would allow FDA to more efficiently gather data, and identify, analyze, and respond to potential problems more quickly, and further improve review times for medical products.

Asked about the support FDA needs from Congress in order to streamline and prioritize inspections and approvals for new domestic facilities to decrease our supply chain reliance on other countries, Woodcock noted that FDA has been working on improving advanced manufacturing, among others.